ESC Premium Access

Prevalence of amyloidosis among patients with mild to severe aortic stenosis. Validation of screening parameters.

Congress Presentation

About the speaker

Doctor Fabian Voss

University Hospital Duesseldorf, Duesseldorf (Germany)
0 follower

8 more presentations in this session

Delays in diagnosis and treatment initiation of ATTR cardiac amyloidosis: a real-world data analysis

Speaker: Doctor J. Vogel (Essen, DE)

Thumbnail

Transthyretin stabiliser therapy in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

Speaker: Mr V. Ribeiro (Teresina, BR)

Thumbnail

Prevalence of transthyretin amyloid cardiomyopathy in patients hospitalised for heart failure with preserved ejection fraction in an LATAM center.

Speaker: Mr S. Decotto (Buenos Aires, AR)

Thumbnail

Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy

Speaker: Doctor J. Vogel (Essen, DE)

Thumbnail

Relationship between changes in renal function after acute phase of tafamidis administration and left ventricular diastolic function at mid-term follow-up in transthyretin cardiac amyloidosis

Speaker: Ms A. Senda (Kobe, JP)

Thumbnail

Access the full session

Cardiac amyloidosis, sarcoidosis, and inflammation

Speakers: Doctor F. Voss, Doctor J. Vogel, Mr V. Ribeiro, Mr S. Decotto, Doctor J. Vogel...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations